Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.3% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
36
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.9% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
22
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
14 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
43.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Swire Properties
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Mixed-use Projects In China And Hong Kong Will Transform Cities
Key Takeaways Expansion in major Chinese cities, strong ESG credentials, and premium tenant engagement drive revenue growth, high occupancy, and robust margins amid rising demand for sustainable spaces. Solid financial position and ongoing premium project launches enable further acquisitions, asset reinvestment, and long-term earnings and dividend growth.
View narrative
HK$23.06
FV
9.1% undervalued
intrinsic discount
11.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
2618
JD Logistics
AN
AnalystConsensusTarget
Consensus Narrative from 19 Analysts
Automation And Global Logistics Expansion Will Reshape Supply Chains
Key Takeaways Emphasis on high-margin services, technology adoption, and international expansion drives revenue diversification and sustained margin improvement. Growth in third-party customers and favorable market trends support long-term earnings momentum and reduce reliance on the parent company.
View narrative
HK$17.55
FV
20.5% undervalued
intrinsic discount
10.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
5 days ago
author updated this narrative
XPO
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
Automation And Regulatory Pressures Will Squeeze Operating Margins
Key Takeaways Rising automation, AI adoption, and new digital competitors threaten XPO's market share, efficiency, and ability to maintain pricing power. Sustainability mandates, labor shortages, and costly tech initiatives are likely to compress margins and impede future earnings growth.
View narrative
US$106.24
FV
26.8% overvalued
intrinsic discount
3.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
United Therapeutics
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Patent Expirations And Biosimilar Pressures Will Diminish Value
Key Takeaways Heavy dependence on a few core drugs heightens risk from patent expirations, increasing vulnerability to revenue declines and competition from generics. Significant investments in novel therapies face technical and regulatory uncertainties, with potential delays and high costs threatening profitability and future earnings.
View narrative
US$295.00
FV
3.5% overvalued
intrinsic discount
1.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
UWM Holdings
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
High Rates And Margin Compression Will Hinder Mortgage Growth
Key Takeaways Reliance on aggressive pricing and traditional broker channels risks margin erosion and limits growth amid rising alternative financing models. Elevated operational complexity and regulatory scrutiny may increase costs and threaten profitability as technology and servicing investments expand.
View narrative
US$4.50
FV
26.4% overvalued
intrinsic discount
7.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Bank Negara Indonesia (Persero)
AN
AnalystConsensusTarget
Consensus Narrative from 21 Analysts
Shift Towards Corporate And Consumer Loans Expected To Improve Future Prospects
Key Takeaways Strategic focus on corporate and consumer loans with digital and branch transformations is expected to improve revenue and net margins. Asset quality improvement and prudent provisioning efforts are likely to stabilize earnings and support sustainable profit growth.
View narrative
Rp5.16k
FV
13.7% undervalued
intrinsic discount
19.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
35
users have followed this narrative
5 days ago
author updated this narrative
RVTY
Revvity
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Regulatory Shifts Will Pressure Diagnostics Yet Spur Measured Turnaround
Key Takeaways Regulatory shifts and market-specific declines threaten revenue growth and earnings recovery, despite innovation and expansion in high-growth segments. Heavy reliance on biopharma and diagnostics exposes Revvity to budget cuts and pricing pressures, undermining revenue stability and margin expansion.
View narrative
US$100.00
FV
7.9% undervalued
intrinsic discount
4.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
RB Global
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Digital Shifts And Decarbonization Will Erode Profit Margins
Key Takeaways Digital transformation and emerging competitors threaten RB Global's traditional auction model, pressuring fees, margins, and long-term revenue growth. Industry trends toward decarbonization and automation reduce demand for used equipment, shrinking the customer base and weakening earnings and profitability.
View narrative
US$99.69
FV
15.4% overvalued
intrinsic discount
8.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Gen Digital
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Open Source Cybersecurity Will Erode Margins Despite Subscription Recovery
Key Takeaways Free cybersecurity alternatives and enhanced device security features are reducing Gen Digital's core recurring revenue and eroding its product differentiation. Regulatory constraints and customer churn threaten personalization, product innovation, and long-term earnings growth.
View narrative
US$25.00
FV
24.5% overvalued
intrinsic discount
7.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies